Table 1.
Health characteristics of 111 pain patients according to diagnostic groups
| Variable | Somatoform-functional pain (n = 62) | Somatic-nociceptive pain (n = 49) | P-value |
|---|---|---|---|
| Age (years) |
47±12 (20–75) |
55±17 (16–84) |
0.005 |
| Female sex (%) |
62.9 |
34.7 |
0.003 |
| Pain duration (months) |
99±115 (3–451) |
17±24 (0.1-100) |
<0.001 |
| Pain level (NRS) |
6.4±2.2 (1–10) |
3.5±1.4 (1–7) |
<0.001 |
| Depressive disorder (%) |
87.1 |
0 |
<0.001 |
| Anxiety disorder (%)1) |
35.5 |
0 |
<0.001 |
| Opioids (%) (includes Tramadol) |
30.2 |
6.1 |
<0.001 |
| NSAIDs (%) (includes Paracetamol and Metamizol) |
50.0 |
93.3 |
0.001 |
| Antidepressants (%) |
85.5 |
0 |
<0.001 |
| Antiepileptics (%) | 24.2 | 0 | <0.001 |
1) includes PTSD.
NSAIDs = non-steroidal anti-inflammatory drugs; NRS = numerical rating scale.
Data are given as means ± SD with range in parentheses or percentage values. Analyses used Mann–Whitney U test and Pearson chi-square test or Fisher’s exact test (where appropriate).